Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
Cell surface glycosylation is dynamic and often changes in response to cellular differentiation under physiological or pathophysiological conditions. Altered glycosylation on cancers cells is gaining attention due its wide-spread occurrence across a variety of cancer types and recent studies that ha...
Main Authors: | Emily Rodrigues, Matthew S. Macauley |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/10/6/207 |
Similar Items
-
Hypersialylation and multiple myeloma
by: Michael O’Dwyer, et al.
Published: (2024-02-01) -
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
by: Heinz Läubli, et al.
Published: (2019-09-01) -
Sialic Acid-Siglec-E Interactions During Pseudomonas aeruginosa Infection of Macrophages Interferes With Phagosome Maturation by Altering Intracellular Calcium Concentrations
by: Kaustuv Mukherjee, et al.
Published: (2020-02-01) -
Targeting cancer-associated glycans as a therapeutic strategy in leukemia
by: Ashraf Abdullah Saad
Published: (2022-12-01) -
Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers
by: Chia-Hsueh Lin, et al.
Published: (2021-01-01)